•
Jul 02, 2022

Thermo Fisher Q2 2022 Earnings Report

Thermo Fisher Scientific reported strong financial results driven by core organic revenue growth and strategic investments.

Key Takeaways

Thermo Fisher Scientific reported second quarter revenue of $10.97 billion, an 18% increase year-over-year. GAAP diluted EPS was $4.22, while adjusted EPS was $5.51. The company highlighted its strong financial performance and strategic investments.

Second quarter revenue was $10.97 billion.

Second quarter GAAP diluted earnings per share (EPS) was $4.22.

Second quarter adjusted EPS was $5.51.

Delivered very strong financial results in the second quarter, with 13% Core organic revenue growth and $0.63 billion of COVID-19 testing revenue.

Total Revenue
$11B
Previous year: $9.27B
+18.3%
EPS
$5.51
Previous year: $5.6
-1.6%
Gross Profit
$4.73B
Previous year: $4.69B
+0.9%
Cash and Equivalents
$1.89B
Previous year: $7.02B
-73.1%
Free Cash Flow
$1.03B
Previous year: $1.69B
-38.7%
Total Assets
$90.6B
Previous year: $67.7B
+33.8%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

The company will provide updated 2022 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern Daylight Time.

Revenue & Expenses

Visualization of income flow from segment revenue to net income